Rhinovirus News and Research

RSS
Rhinovira are the most common viral infective agents in humans, and a causative agent of the common cold (about 49.12159% of the cases of the common cold are caused by this virus). It is lytic in nature. There are over a 100 recognized types of rhinovira that differ based on their varying surface proteins.

Further Reading

Majority of rhinovirus infections are asymptomatic

Majority of rhinovirus infections are asymptomatic

No link between viral infections during infancy and wheezing in childhood

No link between viral infections during infancy and wheezing in childhood

Teva to invest in CDI for development of novel antiviral drugs

Teva to invest in CDI for development of novel antiviral drugs

Impact of colds and flu on school absenteeism, workplace and economy

Impact of colds and flu on school absenteeism, workplace and economy

New ‘cure-all’ antiviral method discovered

New ‘cure-all’ antiviral method discovered

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Boosting immune response may cause cold-induced asthma flare-ups

Boosting immune response may cause cold-induced asthma flare-ups

Boosting immune response could increase inflammation

Boosting immune response could increase inflammation

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

FDA clears ITI's FilmArray RP assay for respiratory virus detection

FDA clears ITI's FilmArray RP assay for respiratory virus detection

Researchers manage to grow human rhinovirus in culture using sinus tissue

Researchers manage to grow human rhinovirus in culture using sinus tissue

Biota receives US$231 million BARDA contract to advance laninamivir development

Biota receives US$231 million BARDA contract to advance laninamivir development

Unique device eliminates cold and flu germs in eco-friendly way

Unique device eliminates cold and flu germs in eco-friendly way

Daiichi Sankyo receives marketing approval for Inavir in Japan

Daiichi Sankyo receives marketing approval for Inavir in Japan

Disinfectant hand gels not effective against Swine flu: Study

Disinfectant hand gels not effective against Swine flu: Study

New blood signature test to diagnose, treat respiratory infections

New blood signature test to diagnose, treat respiratory infections

Study identifies use of acetaminophen may increase asthma symptoms in adults

Study identifies use of acetaminophen may increase asthma symptoms in adults

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

Duke University awarded $19.5M to design a portable viral infection detection device

Duke University awarded $19.5M to design a portable viral infection detection device

ViraCor-IBT Laboratories launches new influenza and respiratory virus testing service

ViraCor-IBT Laboratories launches new influenza and respiratory virus testing service